跳至主要内容
临床试验/EUCTR2013-003220-36-NL
EUCTR2013-003220-36-NL进行中(未招募)1 期

Remifentanil use for procedural sedation and analgesia in the emergency department

Albert Schweitzer hospital0 个研究点开始时间: 2014年1月15日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All the patients who need procedural sedation and analgesia (PSA) at the emergency department or the observatorium of the Albert Schweitzer hospital location Dordwijk in Dordrecht, age 18 years and older, classified as ASA I en II.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Age under 18 years, hemodynamic and/or respiratory instable, classified as ASA III, IV and V, suspicion of elevated intra-cranial pressure, pregnancy, use of opiates at home, opiates administered before PSA procedure started (in the ambulance, on arrival at the emergency department), intoxication, allergy for fentanyl propofol remifentanil soy or chicken proteins.

研究者

相似试验